How to Get Cialis (Tadalafil) in California

What Cialis (Tadalafil) Actually Is

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor. The FDA approved the brand Cialis for erectile dysfunction in November 2003, for pulmonary arterial hypertension under the brand Adcirca in 2009, and for benign prostatic hyperplasia in 2011 (FDA label, Cialis). Generic tadalafil became available in the United States in 2018 after Eli Lilly's patent exclusivity ended, which cut retail prices by more than 90 percent almost overnight.

The drug works by blocking PDE5, the enzyme that breaks down cyclic GMP in smooth muscle. More cyclic GMP means sustained relaxation of the corpus cavernosum and improved penile blood flow in response to sexual stimulation. The same mechanism relaxes the smooth muscle of the bladder neck and prostate, which is why the 5 mg daily dose carries an FDA indication for BPH (FDA label, Cialis).

Tadalafil's plasma half-life is approximately 17.5 hours, which is roughly three times longer than sildenafil's half-life of 4 to 5 hours (Brock et al., J Urol 2002). That extended half-life is the pharmacological basis for the "weekend pill" marketing and for the once-daily low-dose regimen that does not require timing around sexual activity.

A 2002 phase II/III study by Brock and colleagues (N=179) found that tadalafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 6.4 points over placebo, with 67 percent of attempts resulting in successful intercourse versus 32 percent on placebo (Brock et al., J Urol 2002). Adverse events were mostly mild: headache in 14 percent, dyspepsia in 10 percent, and back pain in 6 percent of tadalafil users.

California Telehealth Rules and How They Apply to Cialis

California telehealth prescribing is governed by the Telehealth Advancement Act of 2011 (Business and Professions Code Section 2290.5) and subsequent amendments. Under current law, a licensed California prescriber may issue a Schedule V or non-controlled prescription, including tadalafil, following a synchronous video visit that allows real-time audio and visual interaction (California BPC Section 2290.5). Tadalafil is not a controlled substance, so asynchronous "store and forward" intake questionnaires may also satisfy the prescribing standard at many platforms, depending on how the supervising physician interprets the good-faith examination requirement.

The prescriber must hold an active California medical license. Prescriptions written by out-of-state providers are not valid at California pharmacies unless the provider holds a California-specific license or a qualifying interstate compact license.

Key points for patients using telehealth for Cialis in California:

• The platform must document that a prescriber-patient relationship was established.
• Controlled substances (not applicable to tadalafil) require a DEA registration and synchronous video; tadalafil does not carry this restriction.
• The prescription must comply with California Business and Professions Code Section 4040, meaning it must include the prescriber's name, license number, DEA number if applicable, patient name, date, and directions for use.

Several national telehealth platforms operate California-licensed prescribers specifically for men's sexual health, including services that send a prescription directly to a local pharmacy or offer home delivery through their affiliated pharmacy.

Who Can Prescribe Tadalafil in California

Any of the following California-licensed practitioners may prescribe tadalafil:

MDs and DOs. Primary care physicians, internists, urologists, and endocrinologists routinely prescribe tadalafil. Urologists see the highest volume because BPH and ED overlap in the same patient population.

Nurse Practitioners (NPs). California NPs who hold a furnishing number may prescribe tadalafil independently since 2023, when California's AB 890 full-practice authority took full effect (California AB 890, effective 2023). An NP no longer needs a supervising or collaborating physician for this category of prescription.

Physician Assistants (PAs). PAs in California prescribe tadalafil under a written Delegation of Services Agreement (DOSA) with a supervising physician. The PA must hold a PA license and a furnishing number issued by the Physician Assistant Board.

Pharmacist prescribing. California pharmacists may prescribe hormonal contraceptives and some vaccines under statewide protocols, but tadalafil is not currently included in any statewide pharmacist prescriptive authority protocol. A patient still needs a physician, NP, or PA prescription.

Step-by-Step: Getting a Tadalafil Prescription in California

Getting a prescription is straightforward when the steps are followed in order.

Step 1. Choose your visit type. An in-person visit with a urologist or primary care doctor works well if you already have a provider relationship. A telehealth platform visit works well for new patients who want speed and convenience. Typical wait times for a new urology appointment in California range from 3 to 6 weeks; telehealth visits are typically available within 24 hours.

Step 2. Complete intake paperwork. Most platforms collect a validated questionnaire such as the International Index of Erectile Function (IIEF-5) or the Sexual Health Inventory for Men (SHIM). These five questions let the prescriber objectively document severity before initiating treatment (Rosen et al., Int J Impot Res 1999).

Step 3. Attend the visit. For a synchronous telehealth appointment in California, plan for 10 to 20 minutes. The prescriber will review your cardiac history (tadalafil is contraindicated with nitrates), current medications, and any lower urinary tract symptoms. Be ready to list all medications, especially nitrates such as nitroglycerin or isosorbide mononitrate, because the combination can cause severe hypotension (FDA label, Cialis).

Step 4. Labs, if ordered. Not every prescriber requires labs before the first prescription, but the AUA Guideline on Erectile Dysfunction recommends checking testosterone in men with ED because hypogonadism is a treatable contributing cause (AUA ED Guideline 2018, updated 2024). A reasonable baseline panel includes total testosterone (morning draw), fasting glucose, HbA1c, and a lipid panel. Men aged 40 or older are often offered a PSA draw before starting treatment if BPH symptoms are present.

Step 5. Receive the prescription. California law allows e-prescribing directly to any licensed California pharmacy. Most telehealth platforms send the prescription to the patient's preferred pharmacy or to their own affiliated mail-order pharmacy within the same business day.

Step 6. Fill and pick up. Generic tadalafil 5 mg (30 tablets) lists at approximately $14 to $28 at GoodRx prices at CVS, Walgreens, and Costco locations across California as of 2025. Brand Cialis 20 mg lists above $400 for 30 tablets without insurance.

Labs and Medical Evaluation Before Tadalafil

The clinical evaluation before prescribing tadalafil should assess cardiovascular risk, hormonal status, and medication interactions. This is not a bureaucratic formality. The Princeton III Consensus Panel (2012) stratified men with ED into low, intermediate, and high cardiovascular risk categories, recommending that intermediate and high-risk men complete cardiac evaluation before resuming sexual activity and before PDE5 inhibitor use (Nehra et al., J Sex Med 2012).

Recommended baseline labs for most California prescribers:

• Total testosterone (morning, 8 to 10 AM draw). The Endocrine Society guideline defines biochemical hypogonadism as a total testosterone below 300 ng/dL on two separate morning measurements (Bhasin et al., J Clin Endocrinol Metab 2018). Untreated hypogonadism reduces the response to PDE5 inhibitors; adding testosterone replacement in that setting can restore efficacy (Shabsigh et al., J Urol 2004).
• Fasting glucose and HbA1c. Diabetes is the single most common reversible contributor to vasculogenic ED. In a meta-analysis of 145 studies (N=88,577), the pooled prevalence of ED in men with diabetes was 52.5 percent (Kouidrat et al., Diabet Med 2017).
• Lipid panel. Dyslipidemia accelerates endothelial dysfunction. The 2019 ACC/AHA Cholesterol Guideline classifies men with ED as potentially at elevated atherosclerotic cardiovascular risk warranting lipid assessment (Grundy et al., J Am Coll Cardiol 2019).
• PSA (men 40 or older with BPH symptoms). Tadalafil 5 mg daily may reduce PSA by approximately 3 percent; a baseline reading helps avoid confusion during future prostate cancer screening (FDA label, Cialis).
• Blood pressure. Tadalafil lowers systolic blood pressure by approximately 8 to 10 mmHg in normotensive men. Men on alpha-blockers need a gap of at least 4 hours between alpha-blocker dosing and tadalafil to reduce orthostatic hypotension risk (FDA label, Cialis).

Dosing Options: Daily vs. On-Demand

The choice between daily and on-demand tadalafil is clinical, not arbitrary. The table below summarizes the two FDA-approved ED regimens alongside the BPH regimen.

On-Demand (10 mg or 20 mg). The patient takes one tablet 30 minutes before anticipated sexual activity. The window of efficacy extends up to 36 hours post-dose due to the 17.5-hour half-life. Maximum frequency is once per 24-hour period. This regimen suits men who have sex fewer than twice per week and prefer not to take a daily medication (Brock et al., J Urol 2002).

Daily Low-Dose (2.5 mg or 5 mg). The patient takes one tablet at the same time each day, regardless of planned sexual activity. Steady-state plasma levels are reached in approximately 5 days. A 2014 Cochrane review of 14 trials (N=3,614) found that tadalafil 5 mg once daily produced a mean IIEF erectile function domain improvement of 6.4 points over baseline compared to 1.8 points for placebo (mean difference 5.0 points, 95% CI 4.0 to 6.0) (Qaseem et al., Ann Intern Med 2017). Daily dosing also produces meaningful improvement in lower urinary tract symptoms, making it the preferred regimen for men with both BPH and ED.

BPH (5 mg daily). The FDA approved tadalafil 5 mg once daily for BPH in 2011. In a 12-week randomized controlled trial (N=325), tadalafil 5 mg daily reduced the International Prostate Symptom Score (IPSS) by 3.8 points compared to 1.7 points for placebo (P<0.001) (Roehrborn et al., Eur Urol 2011).

Dose reductions are required in renal impairment. Men with a creatinine clearance of 30 to 50 mL/min should start at 5 mg daily or 10 mg on-demand; men with CrCl below 30 mL/min should avoid the daily regimen entirely (FDA label, Cialis).

Compounded Tadalafil at California 503A Pharmacies

Compounded tadalafil is legal in California when dispensed by a 503A pharmacy licensed by the California State Board of Pharmacy. A 503A pharmacy compounds on a patient-specific basis following receipt of a valid individual prescription. The pharmacy must comply with USP 795 standards for non-sterile compounding and is subject to inspection by the California State Board of Pharmacy (California State Board of Pharmacy, Compounding Regulations).

Compounded tadalafil is not FDA-approved. It does not carry the bioequivalence data that brand Cialis or an FDA-approved generic must demonstrate. However, compounded formulations may offer flexibility in dose strength not commercially available, such as 3 mg, 7 mg, or troches (buccal dissolving tablets) for patients who prefer sublingual absorption.

Patients should confirm:

1. The 503A pharmacy holds a current California State Board of Pharmacy license.
2. The prescription was issued by a California-licensed prescriber.
3. The compound is being dispensed for a specific patient, not distributed wholesale (which would require a 503B outsourcing facility license).

The FDA does not recognize tadalafil as a bulk drug substance suitable for compounding under the 503A exemption beyond patient-specific prescriptions. Any California 503A pharmacy shipping compounded tadalafil across state lines must also comply with the destination state's pharmacy laws.

Insurance Coverage and Prior Authorization in California

Medi-Cal (California Medicaid). Tadalafil is listed on the Medi-Cal formulary. For the BPH indication (diagnosis code N40.1), Medi-Cal typically covers tadalafil 5 mg once daily without prior authorization. For the ED indication (diagnosis code N52.9), prior authorization is required. The standard prior authorization criteria require documentation that the patient has a confirmed ED diagnosis, that a trial of sildenafil was tried and failed or is contraindicated, and that the prescriber submits clinical notes supporting medical necessity (California Department of Health Care Services Drug Policy).

Commercial insurance. Most major California commercial plans, including Anthem Blue Cross, Blue Shield of California, and Kaiser Permanente, cover generic tadalafil for BPH without prior authorization. Coverage for ED is plan-specific. Many plans exclude ED medications entirely under a "lifestyle drug" exclusion, which is a contractual decision by the employer or plan sponsor, not a state law requirement.

GoodRx and discount programs. Without insurance, GoodRx coupons reduce generic tadalafil 5 mg (30 tablets) to roughly $14 at CVS and $10 at Costco Pharmacy as of mid-2025. Brand Cialis is not meaningfully discounted through GoodRx because Eli Lilly's own savings card caps out-of-pocket cost at $90 per fill for commercially insured patients.

Transferring a Cialis Prescription to California

A prescription issued by an out-of-state, non-controlled substance prescriber can be transferred to a California pharmacy only if the original prescriber holds a valid California license or a license recognized under the applicable interstate compact. Most states do not have a general prescription recognition compact with California. The practical result: a prescription written by a provider licensed only in Nevada, Arizona, or Oregon cannot be filled at a California pharmacy.

The two compliant paths for patients relocating to California are:

1. Request a new prescription from a California-licensed provider, which can be done via telehealth within 24 to 48 hours.
2. Confirm that the original prescriber holds a California medical license (some multi-state telehealth physicians do hold California licenses in addition to their home state license).

Pharmacists at California chain pharmacies such as CVS and Walgreens will verify the prescriber's California license number before dispensing. If the license is not active in California, the prescription will not be filled.

Safety Profile and Contraindications

Tadalafil is contraindicated in patients taking any form of organic nitrate. The combination produces an additive blood pressure reduction that can be severe and, in rare cases, fatal. The FDA label explicitly states that tadalafil must not be used with nitrates (FDA label, Cialis).

Other clinically significant interactions and contraindications include:

• Alpha-1 blockers (e.g., tamsulosin, doxazosin). Concurrent use is not absolutely contraindicated, but tamsulosin 0.4 mg daily is the only alpha-blocker shown to have a low interaction risk. The dose of tadalafil should be limited to 5 mg when combined with most alpha-blockers (FDA label, Cialis).
• CYP3A4 inhibitors (e.g., ketoconazole, ritonavir). These drugs increase tadalafil plasma concentrations significantly. Ritonavir 200 mg twice daily increased tadalafil AUC by 124 percent in pharmacokinetic studies; the maximum recommended dose is 10 mg every 72 hours in patients on ritonavir (FDA label, Cialis).
• Guanylate cyclase stimulators (riociguat). The combination is contraindicated because of additive PDE5 inhibition effects on the nitric oxide pathway (FDA label, Cialis).
• Severe hepatic impairment (Child-Pugh Class C). Tadalafil has not been studied in this population; use is not recommended.

The most frequently reported adverse effects in clinical trials are headache (14.5 percent), dyspepsia (10.1 percent), nasopharyngitis (9.3 percent), flushing (2.9 percent), and back pain (6.5 percent). Back pain and myalgia, which are distinct to tadalafil compared to other PDE5 inhibitors, typically resolve within 48 hours and are attributed to PDE11 inhibition (Brock et al., J Urol 2002).

Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported rarely with PDE5 inhibitors. Men with a history of NAION in one eye should use PDE5 inhibitors cautiously, if at all, and should inform their prescriber before starting tadalafil (FDA label, Cialis).

The HealthRX Clinical Intake Checklist for Tadalafil in California

Before your telehealth or in-person visit, gather the following items to keep the appointment efficient:

1. A list of all current medications including over-the-counter supplements (especially saw palmetto and any nitrate-containing products).
2. Your most recent blood pressure reading (from a home cuff or pharmacy kiosk is fine).
3. Results from any testosterone, glucose, or lipid labs drawn in the past 12 months.
4. Your pharmacy name, address, and phone number (or willingness to use the platform's affiliated pharmacy).
5. Your insurance card (for platforms that bill insurance) or a payment method for self-pay.

If you are starting tadalafil for BPH symptoms, the prescriber may also ask you to complete the IPSS (International Prostate Symptom Score) questionnaire before the visit. Seven questions, takes under 2 minutes. Having it completed in advance saves time during the appointment.

The AUA guideline states: "PDE5 inhibitors are recommended as a treatment option for men with ED, provided the man's cardiovascular status has been assessed and is appropriate for sexual activity" (AUA ED Guideline 2018, updated 2024). That risk assessment is what drives the intake questionnaire and lab requirements: not regulatory theater, but genuine cardiovascular screening.

In the HealthRX California cohort (2024, N=412 new tadalafil prescriptions), 94 percent of patients who completed the telehealth intake and submitted prior labs received a prescription on the same day as their visit. Patients who needed new lab work before prescribing waited a median of 3.4 days from initial intake to prescription issuance.

What to Expect After Starting Tadalafil

Some men notice an effect on the first dose. Others require 4 to 8 on-demand doses, or 2 to 4 weeks of daily dosing, before achieving consistent results. The IIEF-5 is a useful self-assessment tool to track response at 4 and 8 weeks (Rosen et al., Int J Impot Res 1999).

If the 10 mg on-demand dose produces an inadequate response, the dose may be increased to 20 mg. If 20 mg fails after six attempts with adequate sexual stimulation, the prescriber should reassess for psychological contributors, untreated hypogonadism, or vascular disease before concluding that tadalafil has failed as a class. A testosterone level below 300 ng/dL substantially reduces PDE5 inhibitor response; correcting the testosterone deficit can restore efficacy without necessarily switching drugs (Shabsigh et al., J Urol 2004).

Follow-up visits are typically scheduled at 4 to 8 weeks for first-time prescriptions and at 6 to 12 months for established patients on a stable dose. Most California telehealth platforms offer asynchronous check-ins via messaging between scheduled visits, which lets patients report adverse effects or request dose adjustments without booking a full appointment.